Company: BIAF
Filing Date: 2025-05-27
Form Type: 424B5
Source: 0001641172-25-012410
Chunk: 22

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-27
Form: 424B5
Chunk 22
---
center'>The date of this prospectus is November 27, 2023.</div>

<div align='center'>TABLE OF CONTENTS</div>

|                                                   | Page |
| About this Prospectus                             |   ii |
| Prospectus Summary                                |    1 |
| Risk Factors                                      |    6 |
| Forward-Looking Statements                        |   33 |
| Use of Proceeds                                   |   34 |
| Description of Capital Stock                      |   35 |
| Description of Debt Securities                    |   39 |
| Description of Warrants                           |   43 |
| Description of Units                              |   45 |
| Legal Ownership of Securities                     |   45 |
| Plan of Distribution                              |   48 |
| Legal Matters                                     |   49 |
| Experts                                           |   49 |
| Where You Can Find More Information               |   49 |
| Incorporation of Certain Information by Reference |   50 |

| i |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the “SEC”) using a “shelf” registration process. Under this shelf registration statement, we may sell from time to time in one or more offerings up to a total dollar amount of $25,000,000 of shares of common stock, preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or as units in combination with other securities as described in this prospectus. Each time we sell any type or series of securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in the documents we have incorporated by reference into this prospectus. To the extent that any statement that we make in a prospectus supplement is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed modified or superseded by those made in a prospectus supplement. You should carefully read both this prospectus and the applicable prospectus supplement and any related free writing prospectus, together with the additional information described under “Where You Can Find